Barton, B.E.; Collins, M.K.; Chau, C.H.; Choo-Wosoba, H.; Venzon, D.J.; Steinebach, C.; Garchitorena, K.M.; Shah, B.; Sarin, E.L.; Gütschow, M.;
et al. Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma. Biomolecules 2024, 14, 725.
https://doi.org/10.3390/biom14060725
AMA Style
Barton BE, Collins MK, Chau CH, Choo-Wosoba H, Venzon DJ, Steinebach C, Garchitorena KM, Shah B, Sarin EL, Gütschow M,
et al. Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma. Biomolecules. 2024; 14(6):725.
https://doi.org/10.3390/biom14060725
Chicago/Turabian Style
Barton, Blaire E., Matthew K. Collins, Cindy H. Chau, Hyoyoung Choo-Wosoba, David J. Venzon, Christian Steinebach, Kathleen M. Garchitorena, Bhruga Shah, Eric L. Sarin, Michael Gütschow,
and et al. 2024. "Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma" Biomolecules 14, no. 6: 725.
https://doi.org/10.3390/biom14060725
APA Style
Barton, B. E., Collins, M. K., Chau, C. H., Choo-Wosoba, H., Venzon, D. J., Steinebach, C., Garchitorena, K. M., Shah, B., Sarin, E. L., Gütschow, M., & Figg, W. D.
(2024). Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma. Biomolecules, 14(6), 725.
https://doi.org/10.3390/biom14060725
